Wells Fargo’s SurgePays SURG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-200
Closed -$356 7253
2024
Q4
$356 Hold
200
﹤0.01% 6329
2024
Q3
$368 Hold
200
﹤0.01% 6188
2024
Q2
$638 Sell
200
-87
-30% -$329 ﹤0.01% 6126
2024
Q1
$1.1K Buy
287
+221
+335% +$1.47K ﹤0.01% 6132
2023
Q4
$426 Buy
66
+4
+6% +$21 ﹤0.01% 6422
2023
Q3
$290 Sell
62
-1,004
-94% -$5.21K ﹤0.01% 6491
2023
Q2
$7.79K Buy
1,066
+1,002
+1,566% +$5.97K ﹤0.01% 5968
2023
Q1
$287 Buy
64
+7
+12% +$38 ﹤0.01% 6673
2022
Q4
$374 Buy
57
+2
+4% +$12 ﹤0.01% 6464
2022
Q3
$0 Buy
55
+7
+15% +$36 ﹤0.01% 7329
2022
Q2
$0 Buy
48
+4
+9% +$17 ﹤0.01% 7455
2022
Q1
$0 Sell
44
-1
-2% -$3 ﹤0.01% 7775
2021
Q4
$0 Buy
+45
New +$115 ﹤0.01% 7780

Other funds holding SURG

Wells Fargo's SURG Position: Q1 2025 in Review

Wells Fargo sold out of SurgePays (SURG) in Q1 2025, closing a stake of 200 shares — an estimated $356 sold.

Wells Fargo first reported a position in SURG in Q4 2021 and held it in 13 quarters. The position peaked at $7.79K in Q2 2023. 29 funds tracked by Wall St. Rank hold SURG as of Q1 2025.

  • Wells Fargo reported no remaining SurgePays position as of Q1 2025 after selling out during the quarter.
  • Wells Fargo sold 200 SurgePays shares in Q1 2025, an estimated $356.
  • Wells Fargo first reported a position in SurgePays in Q4 2021 and held it in 13 quarters.
  • Wells Fargo's SurgePays position peaked at $7.79K in Q2 2023.
  • 29 funds tracked by Wall St. Rank held SurgePays as of Q1 2025.

Based on Wells Fargo's 13F filing for Q1 2025, filed 13 May 2025.